The purpose of this program is to allow patients with diabetes and with specific medical needs which require them to use this investigational inhaled insulin product in order to adequately manage their diabetes. Treatment use of this investigational product is only anticipated when exceptional need is identified by a treating physician on a per patient case by case review.

http://www.clinicaltrials.gov/ct2/show/NCT01459133?term=mannkind&rank=1&submit_fld_opt=